Combining computational neuroscience and body sensor networks to investigate Alzheimer’s disease by unknown
POSTER PRESENTATION Open Access
Combining computational neuroscience and
body sensor networks to investigate Alzheimer’s
disease
Jeroen Bergmann1*, Newton Howard2
From Twenty First Annual Computational Neuroscience Meeting: CNS*2012
Decatur, GA, USA. 21-26 July 2012
Alzheimer’s disease is a syndrome of acquired cognitive
defects that interferes with normal brain function. While
its biochemical effects are well documented, the cause of
Alzheimer’s disease is still not known and the best avail-
able interventions remain merely symptomatic. Different
treatment modalities have been explored over the last
few decades. Pharmaceutical interventions currently con-
sist of medicines that focus on the neuropsychiatric
symptoms and disease-modifying treatments. The impor-
tance of early intervention to the efficacy of treatments
has led to an emphasis on detection and diagnosis in
clinical research, and techniques using imaging, biomar-
kers and genetic information as tools for early detection
have become prevalent. However, multifaceted non-inva-
sive screening tools that incorporate computational algo-
rithms and do not rely on imaging are not being widely
developed. This paper argues that a computation method
originally developed to explain mental processes can be
adapted to assist in the early detection of Alzheimer’s dis-
ease. Temporal changes in behaviour and speech are
occurring in the early stages of the disease. A Body Sen-
sor Network (BSN) can be utilized to collect temporal
information during everyday living which can be further
processed with an algorithm that allows for natural ran-
domness. This method shows that novel non-invasive
screening tools for Alzheimer’s disease can be devised
based on measuring real-life behaviour.
Conclusions
It has been shown that BSNs can be utilized to measure
a range of activities. A MSI classification algorithm can
subsequently categorize the temporal changes during
ADL activities, while allowing for natural occurring ran-
domness [1]. The BSN can be unobtrusive to allow for
monitoring over longer periods of time [2]. The techni-
que outlined here can be used for diagnostic purposes,
but it can also be implemented to screen for treatment
effects of new and existing interventions.
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